Alzheimer's drug study halted early: what we know
NCT ID NCT05522387
First seen Mar 02, 2026 · Last updated Apr 29, 2026 · Updated 8 times
Summary
This study looked at the long-term safety and effects of a drug called XPro1595 in people with Alzheimer's disease who had already finished earlier studies. Only 11 people took part, and the study was stopped early. The main goal was to check for side effects and see if the drug helped with thinking and daily function.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEMENTIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Austin Health
Ivanhoe, Victoria, 3079, Australia
-
Australian Alzheimer's Research Foundation
Perth, Western Australia, 6009, Australia
-
KaRa MINDS
Macquarie Park, New South Wales, 2113, Australia
-
Neuro Trials Victoria Pty Ltd T/A NeuroCentrix
Carlton, Victoria, 3053, Australia
Conditions
Explore the condition pages connected to this study.